Irell & Manella Graduate School of Biological Sciences Faculty

City of Hope's John Kaddis, Ph.D., is an associate professor in the Department of Diabetes & Cancer Discovery Science focusing on type 1 diabetes.

The Brennar Lab dissects the disturbances of the four nicotinamide adenine dinucleotide (NAD) coenzymes - the central catalysts of metabolism - to develop tools that improve health. 

The Deng laboratory studies the homeostasis of uridine and its role in metabolism, which provides a new angle for understanding the pathophysiology of obesity, diabetes and cancer. 

Enrique Montero, M.D., Ph.D., is a research professor within the Arthur Riggs Diabetes & Metabolism Research Institute at City of Hope.

The Sarah Shuck lab is investigating the biochemistry involved when excess sugar damages important molecules such as proteins and DNA.

The Zhao Wang lab focuses on pathological cardiac remodeling due to cardiac hypertrophy, heart failure, cancer treatment, myocardial infarction, senescence and diabetes.

David K. Ann, Ph.D., is the Morgan & Helen Chu Dean's Chair of the Graduate School of Biological Sciences.

Dustin E. Schones, Ph.D., is a researcher with a focus in cancer, obesity and diabetes complications as well as a professor in the Department of Diabetes Complications & Metabolism at the Diabetes & Metabolism Research Institute.

Ke Ma, M.D., Ph.D., is an associate professor in the Department of Diabetes Complications & Metabolism.

Rama Natarajan is the National Business Products Industry Endowed Chair in Diabetes Research, professor and chair in the Department of Diabetes Complications & Metabolism at City of Hope.

Zhen Bouman Chen, Ph.D., is a professor in the Department of Diabetes Complications & Metabolism at Beckman Research Institute of City of Hope in Duarte, California.

Shiuan Chen, Ph.D., chairs the Department of Cancer Biology and Molecular Medicine at the Beckman Research Institute of City of Hope.

WenYong Chen, Ph.D. is an Associate Professor in the Department of Cancer Biology and Molecular Medicine at the Beckman Research Institute of City of Hope.

Robert Hickey, Ph.D., is an Associate Professor in the Department of Cancer Biology and Molecular Medicine at the Beckman Research Institute of City of Hope.

David Horne, Ph.D., vice provost and deputy director of Beckman Institute of the City of Hope and dean of Faculty Affairs, helps shape the scientific and educational vision of City of Hope with his research expertise in Medicinal Chemistry, Drug Development, and Molecular Medicine.

Tijana Jovanovic-Talisman, Ph.D., is an Associate Professor in the Department of Cancer Biology and Molecular Medicine at Beckman Research Institute of City of Hope

John Termini, Ph.D., Associate Director for Shared Resource Management at City of Hope's comprehensive cancer center. He is also a professor of molecular medicine.

City of Hope's John Williams, Ph.D., is a professor in the Department of Cancer Biology and Molecular Medicine and Director of the X-ray Crystallography Core.

Jeremy Stark, Ph.D. is a Professor of Cancer Genetics and Epigenetics

Yilun Liu, Ph.D., is a professor and associate chair of the Department of Cancer Genetics and Epigenetics.

Yanzhong (Frankie) Yang, M.D., Ph.D., is an associate professor in the Department of Cancer Genetics and Epigenetics at Beckman Research Institute of City of Hope.

City of Hope's Richard Ermel Directs and oversees the DCM biomedical and translational research programs.

Ren-Jang Lin, Ph.D., is a professor in the Center fo RNA Biology and Therapeutics, conducting research focusing on the role of RNA splicing and microRNAs in cancer.

Marcia Miller, Ph.D., Professor Emeritus, Center for RNA Biology and Therapeutics, and the Director Emeritus of the Electron Microscopy Core Facility at City of Hope in Los Angeles, CA.

Dr. Branciamore's research interests include (i) investigating the impact of epigenetics on development, disease and evolution, (ii) the application of methods from statistical mechanics and dynamical systems to personalized medicine for the treatment of complex diseases and cancer, and (iii) the

Dr. Palmer's research interests and effort support preclinical and clinical studies concerning the major obstacles to disease control/cure of hematologic malignancies and successful hematopoietic stem cell transplantation.

Andrei S. Rodin, Ph.D., research interests are (i) computational systems biology - both methodology development and application to diverse high-dimensional multiscale biomedical data, and (ii) molecular evolution.

Dr. Rockne serves as director of the Division of Mathematical Oncology and Computational Systems Biology, with the goal of translating mathematics, physics and evolution-based research to clinical care.

Nagarajan Vaidehi, Ph.D., is a scientist, educator and leader with a career-long commitment to developing computational methods to simulate dynamics of proteins involved in signal transduction pathways and using them for the discovery of next generation drugs with lower side effects. Dr. Vaidehi is

Dr. Wu's research interests are in development and application of innovative state-of-the-art bioinformatics techniques and tools that span basic and translational research areas pertaining to genome technologies.

Ya-Huei Kuo, Ph.D., is a professor in the Department of Hematologic Malignancies Translational Science with a research focus in leukemia biology.

Guido Marcucci, M.D., is professor and chair of the Department of Hematological Malignancies Translational Science and chief of the Division of Leukemia.

Ling Li, Ph.D., is an associate professor in Beckman Research Institute's Department of Hematologic Malignancies Translational Science.

Bin Zhang, Ph.D., is an associate professor in the Department of Hematologic Malignancies Translational Science.

Christine Brown, Ph.D., is deputy director of the T Cell Therapeutics Research Laboratories at Beckman Research Institute of City of Hope.

Elizabeth Budde, M.D., Ph.D., is an oncologist and associate professor at City of Hope.

Michael A. Caligiuri, M.D., is a world-renowned physician, scientist, builder, innovator, leader and visionary. He is dedicated to developing the next generation of leading-edge cancer therapies.

Alexey Danilov, M.D., Ph.D., is the Associate Director for Clinical Research Infrastructure, Comprehensive Cancer Center, and Associate Director of the Toni Stephenson Lymphoma Center and professor in the Department of Hematology & Hematopoietic Cell Transplantation.

Don J. Diamond, Ph.D., is Professor in the Department of Hematology & Hematopoietic Cell Transplantation.

Stephen J. Forman, M.D., hematologist-oncologist, is a top cancer doctor for leukemia, lymphoma and bone marrow transplantation. He is also the director of the Hematologic Malignancies Research Institute & director of the T Cell Therapeutics Research Laboratories at City of Hope, Duarte, California

Shoubao Ma, Ph.D., is an assistant professor in City of Hope's Department of Hematology & Hematopoietic Cell Transplantation. Learn about his extensive research

Le Xuan (Truong) Nguyen, Ph.D., is an assistant professor, department of Hematology and Hematopoietic Cell Transplantation at City of Hope, California.

Steven T. Rosen, M.D., is a professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, and executive vice president and director emeritus, Comprehensive Cancer Center and Beckman Research Institute of City of Hope.

Xiuli Wang, Ph.D., is a professor in City of Hope's Department of Hematology & Hematopoietic Cell Transplantation.

City of Hope's Keiichi Itakura, Ph.D., is a professor emeritus, Center for RNA Biology and Therapeutics, and his research focus in on recombinant DNA technology.

Markus Kalkum, Ph.D., is a professor in the Department of Immunology & Theranostics and co-director of the Mass Spectrometry and Proteomics Core.

Helena Reijonen, Ph.D., is an associate professor in the Department of Immunology & Theranostics, City of Hope, California.

John Rossi, Ph.D., is the Lidow Family Research Chair and professor in the Department of Molecular and Cellular Biology and founding director of the Center for RNA Biology and Therapeutics at Beckman Research Institute of City of Hope, specializing in RNA biology.

John Shively, Ph.D., is a professor in the Department of Immunology & Theranostics within the Diabetes & Metabolism Research Institute at City of Hope.

Dr. Zuoming Sun serves as a professor in the Department of Molecular Imaging & Therapy at City of Hope, where his research centers around cancer and immunity

Anna Wu, Ph.D., is chair of the Department of Immunology & Theranostics and co-director of the Center for Theranostic Studies.

Mingye Feng, Ph.D., is an associate professor in the Department of Immuno-Oncology

Javier Gordon Ogembo, Ph.D., is associate professor in the Department of Immuno-Oncology at Beckman Research Institute of City of Hope.

Marcin Kortylewski, Ph.D., is a professor in the Department of Immuno-Oncology, focuses on cancer immunotherapy.

Peter P. Lee, M.D., is professor and chair in the department of Immuno-Oncology, Beckman Research Institute of City of Hope in Southern California and beneficiary of The Christopher Family Endowed Innovation Fund for Alzheimer's Disease and Breast Cancer Research in Honor of Vineta Christopher.

Edwin Manuel, Ph.D., is Assistant Professor in the Department of Immuno-Oncology.

Leo David Wang, M.D., Ph.D., is a pediatric hematologist-oncologist and associate professor in the departments of Immuno-Oncology and Pediatrics.

Hua Yu, Ph.D., associate chair of the Department of Immuno-Oncology, has made STAT3 the focus of much of her research.

Enrique Velazquez Villarreal, M.D., Ph.D., M.P.H., M.S., brings more than 14 years’ expertise to City of Hope in translational multi-omics research, with a particular emphasis on addressing colorectal cancer health disparities in Hispanic/Latino communities.

Aritro Nath, Ph.D., is an Assistant Professor in the Department of Medical Oncology & Therapeutics Research

Edward Newman, Ph.D. is an Associate Professor Emeritus in the Department of Medical Oncology & Therapeutics Research & co-director of the Analytical Pharmacology Core.

Marwan G. Fakih, M.D., is the Deputy Director, Comprehensive Cancer Center, and a medical oncologist specializing in gastrointestinal cancers.

Ravi Salgia M.D., Ph.D., is the Arthur & Rosalie Kaplan Chair in Medical Oncology at City of Hope and an expert in the study and treatment of lung cancer, mesothelioma, thoracic and thymic malignancies and bronchial carcinoids.

Timothy Synold, Pharm,D., is director of the Analytical Pharmacology Core, and a professor in the Department of Medical Oncology & Therapeutics Research at City of Hope.

Stacy W. Gray, M.D., is Director, Clinical and Scientific Strategy, and Vice President, System Strategy, and a professor in the Department of Medical Oncology & Therapeutics Research, Population Sciences.

June-Wha Rhee, M.D.,is a cardio-oncology associate professor in the Division of Cardiology in the Department of Medicine, associate professor in the Department of Stem Cell Biology and Regenerative Medicine at Beckman Research Institute of City of Hope.

Patrick Fueger is an Associate Professor, Department of Molecular & Cellular Endocrinology.

Chair, Department of Molecular & Cellular Endocrinology; Ruth B. and Robert K. Lanman Endowed Chair in Gene Regulation and Drug Discovery Research

Debbie C. Thurmond, Ph.D., is director of the Arthur Riggs Diabetes & Metabolism Research Institute at City of Hope and chair and professor in the Department of Molecular & Cellular Endocrinology.

Qiong (Annabel) Wang, Ph.D. is an assistant professor in the Department of Molecular & Cellular Endocrinology.

Linda Malkas, Ph.D., is a professor in the Department of Molecular Diagnostics & Experimental Therapeutics at Beckman Research Institute of City of Hope.

Ajay Goel, Ph.D., AGAF, Associate Director for Basic Science, Comprehensive Cancer Center; Professor and Chair, Department of Molecular Diagnostics and Experimental Therapeutics, researches molecular pathogenesis of human gastrointestinal cancers and its relationship to early detection of cancer.

Jeff Perry, Ph.D., is an assistant professor in the Department of Cancer Biology and Molecular Medicine at City of Hope Cancer Center Duarte, California.

Disease modeling and therapeutic development for neurological diseases and cancer.

Christiane Querfeld, M.D., Ph.D., is a dermatologist and dermatopathologist who specializes in the diagnosis and treatment of cutaneous lymphoma.

Dr. John Chan is a hematopathologist at City of Hope’s Toni Stephenson Lymphoma Center. 

Dr. Lior Goldberg leads City of Hope's Pediatric and Young Adult Cancer Cell Therapeutic Lab. As a physician-scientist, Dr. Goldberg helps patients and families directly by overseeing treatment and on a broader scale through his work developing new therapies. 
 

Pediatric hematologist-oncologist Saro Armenian, D.O., M.P.H., is the Barron Hilton Chair in Pediatrics, with expertise in pediatric cancer, epidemiology and cancer survivorship.

Marta Jankowska received her Ph.D. at San Diego State University and University of California, Santa Barbara, where she also did postdoctoral work in family medicine and public health.

Mark LaBarge is a Professor in the Department of Population Sciences with a focus on breast cancer research.

Susan L. Neuhausen, Ph.D., is The Morris & Horowitz Families Professor in Cancer Etiology & Outcomes Research at Beckman Research Institute of City of Hope. She conducts research focused on identifying genes that predispose to disease.

Narissa Nonzee, Ph.D., is a health services researcher and Assistant Professor in the Division of Health Equities within the Department of Population Sciences at City of Hope.

Victoria Seewaldt, M.D., Associate Director for Population Sciences, Comprehensive Cancer Center and Ruth Ziegler Chair and Professor of the Department of Population Sciences, with a clinical specialty in breast cancer.

Christopher Sistrunk, Ph.D., is an associate professor in the Department of Population Sciences at City of Hope

Lindsey S. Treviño, Ph.D. is an assistant professor in the Division of Health Equities and Department of Population Sciences.

Susanta Hui, Ph.D., is a Professor, Department of Radiation Oncology at City of Hope in Duarte, CA.

Terence M. Williams, M.D., Ph.D., is professor and chair of the Department of Radiation Oncology, City of Hope in Duarte, Southern California.

Heather McGee, M.D., Ph.D., is an assistant professor in the Department of Radiation Oncology and Department of Immuno-Oncology at City of Hope.

Transcriptional Control of Tumor Cell Dissemination and Metastasis.

Translational Research - Neural Stem Cell as Delivery tool for Cancer Treatment.

At the Intersection of neurobiology and immuno-oncology.

Modulation of the bone marrow niche to redirect cellular networks in stress and malignant hematopoiesis

Regulation of Neural Progenitor Cell Proliferation and Differentiation in Brain Development and Tumor Formation.

Lisa Feldman, M.D., Ph.D., is a neurosurgeon and assistant professor in the Department of Surgery at City of Hope.

Behnam Badie, M.D., is a renowned neurosurgeon and expert in the field of surgical neuro-oncology, nanotechnology and T cell research.

A prolific researcher and talented surgeon, Mike Y. Chen, M.D., Ph.D., has been on City of Hope's neurosurgery team since 2007. He specializes in complex operations for the removal of brain and spine tumors.

Saswati Chatterjee, Ph.D., is a professor in the Department of Surgery conducting research focusing on evaluating genetic modification of hematopoietic stem cells.

Thanh H. Dellinger, M.D., is a gynecologic oncologist focusing on ovarian cancer, cervical cancer, uterine cancer, robotic surgery and fertility sparing cancer treatments.

Yuman Fong, M.D., is an internationally recognized expert in cancer of the liver, gallbladder and bile ducts. He has led the research effort to employ genetically modified viruses to destroy cancer cells.

City of Hope's neurosurgeon and scientist, Rahul Jandial, M.D., Ph.D., specializes in brain, spine and spinal cord cancers.

Ellie Maghami, M.D., is a head, neck and thyroid cancer surgeon and The Norman and Sadie Lee Foundation Endowed Professor in Head and Neck Cancer.

Nora Heisterkamp, Ph.D. is a research professor in the Department of Systems Biology in Beckman Research Institute of City of Hope.

Jianjun Chen, Ph.D., is the Simms/Mann Family Foundation Chair in Systems Biology, professor and chair in the Department of Systems Biology, and director for the Center for RNA Biology and Therapeutics at City of Hope.

Mark Boldin, Ph.D., is an associate professor, in the Department of Systems Biology, at Beckman Research Institute of City of Hope. His focus is on leukemia and stem cell biology research.

Xiaolan Deng, Ph.D, is an Associate Professor in the Department of Systems Biology at City of Hope.

Rui Su, Ph.D., is an assistant professor in the Department of Systems Biology.

Vu Nguyen Ngo, Ph.D., is an associate professor in the Department of Systems Biology at Beckman Research Institute of City of Hope.

Srividya Swaminathan, Ph.D., is an associate professor in the Department of Systems Biology.

Dr. Gu's research focus is to integrate multi-omics platforms, advanced analytical approaches, and multiple experimental models to study the heterogeneity of acute leukemias and facilitate the development of more efficacious targeted therapies.

Cristian Tomasetti, Ph.D., is the director of City of Hope's Center for Cancer Prevention and Early Detection, director of the Division of Mathematics for Cancer Evolution and Early Detection in the Department of Computational and Quantitative Medicine at Beckman Research Institute of City of Hope

Ben Hung Ping Shih, Ph.D., is an associate professor at City of Hope's Arthur Riggs Diabetes & Metabolism Research Institute.

Jiing Kuan Yee, Ph.D., is a professor, researcher and is expert in the development of genome editing for disease modeling and cell-based therapy at Beckman Research Institute of City of Hope.

Rupangi Vasavada, Ph.D., is a professor in the Department of Translational Research & Cellular Therapeutics

Sangeeta Dhawan, Ph.D., is an associate professor in the Department of Translational Research & Cellular Therapeutics within the Arthur Riggs Diabetes & Metabolism Research Institute.

Teresa Ku, Ph.D., | Associate Professor, Translational Research & Cellular Therapeutics | City of Hope